We are please to report that CARMA has received approval from the Ethics Committee in Spain. This multi-centre, cross-sectional study of children with perinatally acquired HIV-1 on sustained suppressive antiretroviral therapy started before 2 years of age will start enrolling in the next few weeks. Submissions in Italy and the UK are ongoing and expected soon.